Human spermatozoa pass a torturous journey during fertilization. A slight deviation from 1:l has been observed in the sex ratio and a number of variables ranging from seasonal, religious days and posit~on of females during mating have been implicated in producing offsprings ofa desired gender. The selective choice of sperm by a female based on the aforementioned factors [superstitions] has not been substantiated. In this investigation wr collected data from 2,071 pregnant women who visited our two laboratories for genetic amniocentesis during the past two decades. The Pediatric Genetics laboratory at LSU School of Medicine in Shreveport, LA, began offering prenatal service in NTD and chromosomal defect screening through triple screening program since 1995. The laboratory also began epidemiological research studies on the newborn population of Northwest Louisiana for several genetic disease mutations for the past 4 years as part of March of Dimes birth defects foundation and LSU foundation grants. We have recently reported the gene frequencies for MCAD deficiency, Factor V Leiden in our population and as part of thrombophilia markers we also started investigating the frequencies of MTHFR C677T and prothrombin G20210A polymorphism. Our local population composed of 76% African-Americans, 20% Caucasians, 2% Hispanics, and the rest other ethnic groups. Following English multicenter multivitamin studies on NTD in 1970 and '72 revealing possible risk reduction in recurrences of NTD with periconceptional supplementation of folic acid, folate-activating enzyme, MTHFR, has become the subject of intense study in various diseases. MTHFR was also linked to cardiovascular diseases through hyperhomocystinemia and recently to other complex genetic traits such as Orofacial clefts
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In our polymorphism studies, the carrier and homozygous C677T frequencies were found to be 24% and 3 5%, respectively, in the total population. However, on stratification by ethnicity, we found that the hetrozygote and homozygote frequencies were 18%, 46%, 45%, and 0.9%, 21%, 1 I%, respectively, in African-Americans, Hispanics and Caucasians. Our data found higher C677T homozygotes in our Hispanic newborn population than other ethnic groups and may explain the higher frequency of NTDs and Orofacial Clefts found in this population Fetal methotrexate syndrome. M.E. wheeler' , M Stanford', P. 0' Meara'. 'Denver Health Medical Center, Denver, and 'Unrvers~ty of Colorado, Denver.
Fetal methotrexate syndrome was first described several decades ago when this agent was bang used as abomfactenf. After thls first trimester drug exposure was assocrated wrth fetal anomalres, this use as abon~facient became rare. Over the last several years the use ofmethotrexate for termmation of pregnancy and med~cal management of ectopic pregnancies bas agam become more w~despread. Case: A 23 year old G, P,female sought an abortion at 8 weeks of gestatlon. She was glven an unhown dose ofmethocexate. She had no follow-up until she presented at 10 weeks of gestation At that tune she was noted to have a viable intrauterine gestation. An ultrasound was done that showed a normal scan for 10 weeks of gestation. The patient had no prenatal care until she presented at 39 weeks of gestatlon. At that tlrne she was noted to have severe preecalmpsia and HELLP syndrome. The fetus on ul&asound was symmetrrcally growth retarded wrth estrmated fetal we~ght at less than the 5" percentile. Secondary to a breech presentatron the Infant was delivered by cesarean section. The infant was small for gestahonal age at 2050grams whlch is at the first percenhle by the Lubcenco intrautertne growth standard On physical exam the rnfant was hypoton~c with the following anomalies: mlld dol~hocephaly, high forehead, prominent, broad nose, hypertelorism., small palpebral fissures, sacral crease, small mouth, clinodactaly, and hypoplastrc toe nads. The mfant's hospttal course was complicated by temperature instablllty A head C7 and ultrasound were negative for any pathology. Chromosomes were normal. After a 7 day hospital course the rnfant was d~scharged home wrth a cardlac and resprratory monitor. D~scursron: Metbotrexate have been extensively use in auto~mmune d~sorder and as chemotherapy. Slnce thelr use IS becoming more extensive as a abort~facient and for the medical management of ectop~c pregnancres, we wtll see many cases of first trimester FXpOSUre of fetuses to thrs agent T h~s exposure should be cons~dsred when readrly offered by the mother.
